Skip to main content
. 2024 Nov 26;2024(11):CD013707. doi: 10.1002/14651858.CD013707.pub2
Treatment RR 95% CI lower limit 95% CI upper limit z P
Levosimendan + Dobutamine 0.3333 0.0371 2.9910 ‐0.98 0.3264
Milrinone + Dobutamine reference reference reference reference reference